Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption

Anna Campanati; Elisa Molinelli; Valerio Brisigotti; Donatella Brancorsini; Ivan Bobyr; Federico Diotallevi; Giulia Radi; Annamaria Offidani

doi:10.1159/000501992

Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption

Case Rep Dermatol. 2019 Sep 23;11(Suppl 1):4-10. doi: 10.1159/000501992. eCollection 2019 Sep-Dec.

Authors

Anna Campanati¹, Elisa Molinelli¹, Valerio Brisigotti¹, Donatella Brancorsini², Ivan Bobyr¹, Federico Diotallevi¹, Giulia Radi¹, Annamaria Offidani¹

Affiliations

¹ Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
² Institute of Pathological Anatomy and Histopathology, Polytechnic Marche University, Ancona, Italy.

Abstract

Kaposi's varicelliform eruption (KVE) is a disseminated cutaneous infection usually induced by herpesvirus type 1 or 2, vaccinia virus or Coxsackie A16 virus in a patient with an underlying dermatosis. Risk factors for KVE reported in the literature include erythroderma, systemic sepsis, therapy with immunosuppressants such as methotrexate and systemic steroids, and therapy with systemic retinoids. The occurrence of KVE in psoriasis is rare and it predominantly appears in patients affected by erythrodermic psoriasis during immunosuppressive treatment. We report our experience of a remarkable case of a patient affected by severe erythrodermic psoriasis and KVE that healed after antiviral treatment and after having received secukinumab. After 1 year, psoriasis was cleared and no recurrence of KVE had occurred.

Keywords: Herpes simplex virus; Psoriasis; Secukinumab.

Publication types

Case Reports